COVID-19 in Children Following Hematopoietic Cell Transplantation: A Multinational Study of the European Bone Marrow Transplantation Society (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH)

Introduction COVID-19 is usually a mild disease in immunocompetent children, with ~1% requiring intensive care unit (ICU) admission and <0.1% mortality. Data on its course in children following hematopoietic cell transplantation (HCT) is limited. Methods Data on children following HCT who develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Averbuch, Diana, De La Camara, Rafael, Corbacioglu, Selim, Mikulska, Malgorzata, Piñana Sanchez, Jose Luis, Tridello, Gloria, Knelange, Nina Simone, Kulagin, Aleksandr D., Ayas, Mouhab, Perez-Martinez, Antonio, Hamidieh, Amir Ali, Sundin, Mikael, Martino, Rodrigo, Sedlacek, Petr, Cesaro, Simone, Paillard, Catherine, Gibson, Brenda, Lawson, Sarah, Kroeger, Nicolaus, Styczynski, Jan, Ljungman, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
721.Allogeneic Transplantation: Conditioning Regimens, Engraftment and Acute Toxicities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701543/
http://dx.doi.org/10.1182/blood-2021-146748

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701543/
http://dx.doi.org/10.1182/blood-2021-146748

Ejemplares similares